Philips reported its second-quarter 2025 earnings with revenue of €4.34 billion, slightly above estimates of €4.33 billion. Comparable sales increased by 0.6%, reversing expectations of a 0.54% decline, while adjusted EBITA reached €540 million, surpassing the estimated €428.8 million. The company also saw a 6% rise in comparable order intake. Philips raised its full-year adjusted EBITA margin outlook to a range of 11.3% to 11.8%, above the prior estimate of 11.2%, citing a lower-than-expected impact from tariffs following a US-EU trade deal. The tariff impact is now expected to be between $173 million and $232 million, substantially less than previous estimates. Philips' shares rose by around 9-10% on the news, supported by strong sales, order momentum, and operational improvements such as localized production. The company is also seeking healthcare tariff exemptions and has increased its free cash flow guidance. In related healthcare sector earnings, Siemens Healthineers posted Q3 2025 revenue of €5.66 billion, matching estimates, with adjusted EBIT of €953 million, beating the €890 million forecast. Siemens Healthineers raised its full-year adjusted EPS guidance to a range of €2.30 to €2.45 and expects comparable sales growth between 5.5% and 6%. GE HealthCare reported Q2 2025 revenue of $5.00 billion, above the $4.96 billion estimate, with net income of $486 million and adjusted EPS of $1.06, exceeding the $0.92 forecast. GE HealthCare's adjusted free cash flow was $94 million, and it projects full-year organic growth of 2% to 3%. Kraft Heinz also released Q2 2025 results, with adjusted EPS of $0.69 beating estimates of $0.64, revenue of $6.35 billion surpassing the $6.26 billion forecast, but maintained a negative full-year organic growth outlook between -3.5% and -1.5%.